156 related articles for article (PubMed ID: 37656041)
21. Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining Guidelines to Assess the Clinical Benefit of Cancer Immunotherapy.
Hodi FS; Ballinger M; Lyons B; Soria JC; Nishino M; Tabernero J; Powles T; Smith D; Hoos A; McKenna C; Beyer U; Rhee I; Fine G; Winslow N; Chen DS; Wolchok JD
J Clin Oncol; 2018 Mar; 36(9):850-858. PubMed ID: 29341833
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Utility of Parameters Derived From Pretreatment Dual-Layer Spectral-Detector CT in Patients With Metastatic Renal Cell Carcinoma.
Drljevic-Nielsen A; Donskov F; Mains JR; Andersen MB; Thorup K; Thygesen J; Rasmussen F
AJR Am J Roentgenol; 2022 May; 218(5):867-876. PubMed ID: 34910540
[No Abstract] [Full Text] [Related]
23. The effect of baseline morphology and its change during treatment on the accuracy of Response Evaluation Criteria in Solid Tumours in assessment of liver metastases.
Schiavon G; Ruggiero A; Bekers DJ; Barry PA; Sleijfer S; Kloth J; Krestin GP; Schöffski P; Verweij J; Mathijssen RH
Eur J Cancer; 2014 Mar; 50(5):972-80. PubMed ID: 24480402
[TBL] [Abstract][Full Text] [Related]
24. Discrepant Assessments of Progressive Disease in Clinical Trials between Routine Clinical Reads and Formal RECIST 1.1 Interpretations.
Siegel MJ; Ippolito JE; Wahl RL; Siegel BA
Radiol Imaging Cancer; 2023 Sep; 5(5):e230001. PubMed ID: 37540134
[TBL] [Abstract][Full Text] [Related]
25. Comparison of central and local serial CT assessments of metastatic renal cell carcinoma patients in a clinical phase IIB study.
Felsch M; Zaim S; Dicken V; Lehmacher W; Scheuring UJ
Acta Radiol; 2017 Feb; 58(2):249-255. PubMed ID: 27083205
[TBL] [Abstract][Full Text] [Related]
26. Assessing tumor response and detecting recurrence in metastatic renal cell carcinoma on targeted therapy: importance of size and attenuation on contrast-enhanced CT.
Smith AD; Lieber ML; Shah SN
AJR Am J Roentgenol; 2010 Jan; 194(1):157-65. PubMed ID: 20028918
[TBL] [Abstract][Full Text] [Related]
27. Morphology, Attenuation, Size, and Structure (MASS) criteria: assessing response and predicting clinical outcome in metastatic renal cell carcinoma on antiangiogenic targeted therapy.
Smith AD; Shah SN; Rini BI; Lieber ML; Remer EM
AJR Am J Roentgenol; 2010 Jun; 194(6):1470-8. PubMed ID: 20489085
[TBL] [Abstract][Full Text] [Related]
28. Evaluating the agreement between tumour volumetry and the estimated volumes of tumour lesions using an algorithm.
Laubender RP; Lynghjem J; D'Anastasi M; Heinemann V; Modest DP; Mansmann UR; Sartorius U; Schlichting M; Graser A
Eur Radiol; 2014 Jul; 24(7):1521-8. PubMed ID: 24816938
[TBL] [Abstract][Full Text] [Related]
29. Comparison of volumetric and linear serial CT assessments of lung metastases in renal cell carcinoma patients in a clinical phase IIB study.
Dicken V; Bornemann L; Moltz JH; Peitgen HO; Zaim S; Scheuring U
Acad Radiol; 2015 May; 22(5):619-25. PubMed ID: 25778472
[TBL] [Abstract][Full Text] [Related]
30. CT response assessment combining reduction in both size and arterial phase density correlates with time to progression in metastatic renal cancer patients treated with targeted therapies.
Nathan PD; Vinayan A; Stott D; Juttla J; Goh V
Cancer Biol Ther; 2010 Jan; 9(1):15-9. PubMed ID: 20009542
[TBL] [Abstract][Full Text] [Related]
31. CT-based whole-body tumor volumetry versus RECIST 1.1: Feasibility and implications for inter-reader variability.
Zimmermann M; Kuhl CK; Engelke H; Bettermann G; Keil S
Eur J Radiol; 2021 Feb; 135():109514. PubMed ID: 33401109
[TBL] [Abstract][Full Text] [Related]
32. Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial CT scan-based study.
Werner-Wasik M; Xiao Y; Pequignot E; Curran WJ; Hauck W
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):56-61. PubMed ID: 11516851
[TBL] [Abstract][Full Text] [Related]
33. The role of early ¹⁸F-FDG PET/CT in prediction of progression-free survival after ⁹⁰Y radioembolization: comparison with RECIST and tumour density criteria.
Zerizer I; Al-Nahhas A; Towey D; Tait P; Ariff B; Wasan H; Hatice G; Habib N; Barwick T
Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1391-9. PubMed ID: 22644713
[TBL] [Abstract][Full Text] [Related]
34. The Attenuation Distribution Across the Long Axis of Breast Cancer Liver Metastases at CT: A Quantitative Biomarker for Predicting Overall Survival.
Abramson RG; Lakomkin N; Hainline A; Kang H; Hutson MS; Arteaga CL
AJR Am J Roentgenol; 2018 Jan; 210(1):W1-W7. PubMed ID: 29064750
[TBL] [Abstract][Full Text] [Related]
35. Validity of RECIST Version 1.1 for Response Assessment in Metastatic Cancer: A Prospective, Multireader Study.
Kuhl CK; Alparslan Y; Schmoee J; Sequeira B; Keulers A; Brümmendorf TH; Keil S
Radiology; 2019 Feb; 290(2):349-356. PubMed ID: 30398433
[TBL] [Abstract][Full Text] [Related]
36. Assessment of objective responses using volumetric evaluation in advanced thymic malignancies and metastatic non-small cell lung cancer.
Force J; Rajan A; Dombi E; Steinberg SM; Giaccone G
J Thorac Oncol; 2011 Jul; 6(7):1267-73. PubMed ID: 21610525
[TBL] [Abstract][Full Text] [Related]
37. Comparing RECIST with EORTC criteria in metastatic bladder cancer.
Öztürk H
J Cancer Res Clin Oncol; 2016 Jan; 142(1):187-94. PubMed ID: 26208817
[TBL] [Abstract][Full Text] [Related]
38. Tumor response assessment: comparison between unstructured free text reporting in routine clinical workflow and computer-aided evaluation based on RECIST 1.1 criteria.
Goebel J; Hoischen J; Gramsch C; Schemuth HP; Hoffmann AC; Umutlu L; Nassenstein K
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2527-2533. PubMed ID: 28825135
[TBL] [Abstract][Full Text] [Related]
39. Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0.
Shady W; Kishore S; Gavane S; Do RK; Osborne JR; Ulaner GA; Gonen M; Ziv E; Boas FE; Sofocleous CT
Eur J Radiol; 2016 Jun; 85(6):1224-31. PubMed ID: 27161074
[TBL] [Abstract][Full Text] [Related]
40. Comparison of treatment response classifications between unidimensional, bidimensional, and volumetric measurements of metastatic lung lesions on chest computed tomography.
Tran LN; Brown MS; Goldin JG; Yan X; Pais RC; McNitt-Gray MF; Gjertson D; Rogers SR; Aberle DR
Acad Radiol; 2004 Dec; 11(12):1355-60. PubMed ID: 15596373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
